Lument Finance Trust, Inc. (LFT) Market Cap
Lument Finance Trust, Inc. has a market capitalization of $69.2M.
Financials based on reported quarter end 2025-12-31
Price: $1.32
▲ 0.03 (2.33%)
Market Cap: 69.17M
NYSE · time unavailable
CEO: James Peter Flynn
Sector: Real Estate
Industry: REIT - Mortgage
IPO Date: 2013-03-22
Website: https://lumentfinancetrust.com
Lument Finance Trust, Inc. (LFT) - Company Information
Market Cap: 69.17M · Sector: Real Estate
Lument Finance Trust, Inc., a real estate investment trust, focuses on investing in, financing, and managing a portfolio of commercial real estate (CRE) debt investments in the United States. The company primarily invests in transitional floating rate commercial mortgage loans on middle market multi-family assets; and other CRE -related investments, including mezzanine loans, preferred equity, commercial mortgage-backed securities, fixed rate loans, construction loans, and other CRE debt instruments. Lument Finance Trust, Inc. is qualified as a real estate investment trust (REIT) under the Internal Revenue Code of 1986. As a REIT, it would not be subject to federal income taxes if it distributes at least 90% of its taxable income to its stockholders. The company was formerly known as Hunt Companies Finance Trust, Inc. and changed its name to Lument Finance Trust, Inc. in December 2020. Lument Finance Trust, Inc. was incorporated in 2012 and is headquartered in New York, New York.
Analyst Sentiment
Based on 2 ratings
Consensus Price Target
No data available
Price & Moving Averages
Related Companies in Real Estate
FRANKLIN STREET PROPERTIES REIT CO (FSP)
Real Estate
$0.07B
Mkt Cap
ADVANCED FLOWER CAPITAL INC (AFCG)
Real Estate
$0.07B
Mkt Cap
CLIPPER REALTY INC (CLPR)
Real Estate
$0.05B
Mkt Cap
MOBILE INFRASTRUCTURE CORP (BEEP)
Real Estate
$0.09B
Mkt Cap
SUNRISE REALTY TRUST INC (SUNS)
Real Estate
$0.11B
Mkt Cap
RITHM PROPERTY INC TRUST (RPT)
Real Estate
$0.11B
Mkt Cap
Management sounded cautiously constructive: credit metrics improved sequentially (risk rating improved to 3.2 from 3.6) and FL3 adds $400 million of funded loan activity with portfolio liquidity. However, the Q&A shows the market is still pressing on earnings power and dividend coverage. Nonaccruals still create a measurable drag (~$0.02) on ~$102 million UPB even after the new loan book was added, and the credit story is dominated by a large Q4 credit provision ($8.6 million unrealized provision; specific allowance up to $17.6 million). The dividend discussion admits coverage restoration is not automatic—management framed the path as “a little bit of both” cleaning up existing legacy/REO and redeploying capital, plus possible additional portfolio-level financing (another CLO or a second vehicle). While forward actions (JPM repurchase capacity, Northeast warehouse) and schedule adherence were emphasized, the operational hurdle remains timely resolution of challenged legacy assets rather than near-term growth.
Growth Catalysts
- FL3 CLO closed and fully deployed; added $383 million of assets from an affiliate of the manager (initial collateral for the ~$400 million Q4 funding)
- Portfolio credit metrics improved sequentially (weighted average risk rating improved to 3.2 from 3.6) driven primarily by acquisition of additional performing loans tied to FL3
- Loan-level nonaccrual/credit cleanup via a modification: transitioned 1 loan with UPB $9.8 million from risk rating 5 to 4 or better (partial paydown + extension until Q4 2026)
Business Development
- JPMorgan Chase uncommitted master repurchase agreement (entered Nov 2025): up to $450 million borrowing capacity
- Northeast Bank loan agreement (entered early Dec 2025): up to $50 million advances to finance portions of the investment portfolio; used for flexibility to resolve REO
- Executed LMNT 2025-FL3 CLO (Dec 2025): $664 million transaction; effective advance rate 88%
Financial Highlights
- GAAP net loss to common stockholders: $8.9 million (loss of $0.17/share) in Q4 2025; GAAP net loss for FY 2025: $0.14/share
- Q4 distributable earnings: approximately $0/share (company reported distributable earnings ~0 for Q4)
- Net interest income: $5.3 million in Q4 vs $5.1 million in Q3
- Weighted average loan portfolio coupon declined to 717 bps from 777 bps (sequential) due to lower spreads on newly acquired loans and decline in SOFR benchmark
- Operating expenses rose to $3.8 million from $3.1 million in Q3, driven by one-time legal expenses related to REO, FL1 redemption in Nov, and an elected financing initiative not pursued after securing more attractive facility terms
- Unrealized provision for credit losses: $8.6 million (primary driver of difference between net income and distributable earnings)
- Allowance for credit losses: specific allowance increased to $17.6 million from $8.3 million (Sept 30); general allowance decreased to $5.0 million from $5.7 million
- At Dec 31, 8 loans risk-rated 5 with aggregate principal ~$117 million (~10% of UPB)
Capital Funding
- FL3 CLO: $664 million; effective leverage/advance rate 88%; weighted average cost of funds ~SOFR + 191 bps (excluding fees/transaction costs)
- Q4 deployment/payoffs: $400 million deployed into loan assets; $104 million of loan payoffs used primarily to reduce securitization liabilities
- Unrestricted cash: ~$23 million at Dec 31, 2025
- Secured corporate term loan amended post-quarter end: maturity extended to 2030; incremental $2.3 million liquidity before fees/deal expenses; interest rate 9.75%
- Total book equity: ~$219 million; total book value of common stock: ~$159 million or $3.03/share (down from $3.25/share at Sept 30)
Strategy & Ops
- Active asset management prioritized: modifications/extensions and asset-level strategies; disciplined management of positions impacted by supplier capital-structure challenges
- REO resolution: foreclosed on 4 REO assets during 2025; in late Dec sold San Antonio, TX property for $8.2 million and recognized ~$0.5 million loss in Q4
- REO inventory at Dec 31: 3 multifamily properties (San Antonio x1, Houston x1); weighted average occupancy rate 69%
- Fully deployed FL3 CLO by quarter end
Market Outlook
- Dividend coverage planning for 2026 referenced as moving back toward full coverage of the $0.04/share dividend; no explicit numeric Q1 2026 guidance provided
- Management expectation: legacy asset resolutions/payoffs moving 'according to plan and relatively on schedule' into 2026; insufficient detail to quantify
Risks & Headwinds
- Credit losses/allowance volatility: recorded provision for credit losses of ~$8.6 million in Q4; specific allowance jumped to $17.6 million from $8.3 million
- Nonaccruals/earnings drag: analyst asked about nonaccrual drag; management stated drag about $0.02 and UPB ~$102 million at year-end
- Pressured transitional asset debt service coverage (noted in prepared remarks) despite modest easing in index rates
- Higher operating expense base from one-time legal costs and prior financing actions (FL1 redemption; financing initiative not proceeded)
- Legacy REO occupancy and recovery challenge: REO occupancy averaged 69%, ongoing asset resolution required
Sentiment: MIXED
Note: This summary was synthesized by AI from the LFT Q4 2025 (reported 2026-03-24) earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.
Fundamentals Overview
📊 AI Financial Analysis
Powered by StockMarketInfo"Lifetrasure (LFT) reported revenue of $17.9M for the quarter ended 2025-12-31, with net income of -$7.8M and EPS of -$0.17, translating to a net margin of about -43%. Free cash flow was $1.3M (operating cash flow $1.3M) with capital expenditure reported as $0, but liquidity and earning power remain challenged given the magnitude of the net loss. On the balance sheet, total assets were $1.22B versus total liabilities of $1.00B, leaving equity of $219.1M. Net debt was $965.0M, indicating high leverage relative to equity and limited financial flexibility if cash generation weakens. Shareholder returns have been pressured: the stock is down -52.2% over 1 year and -37.9% over 6 months. Cash returns via dividends appear modest (about $0.04 per quarter most recently, with $0.06 previously), and buybacks are not provided. With weak profitability, minimal FCF relative to net debt, and limited valuation/analyst data, investor support would typically rely on improving fundamentals rather than current fundamentals alone. "
Revenue Growth
Revenue is $17.9M for the quarter, but no prior-period figures are provided to assess growth or drivers. As a result, stability vs. acceleration cannot be confirmed.
Profitability
Net income of -$7.8M and EPS of -$0.17 imply a net margin of roughly -43%, indicating significant profitability stress and inefficient cost/earnings conversion.
Cash Flow Quality
Free cash flow was $1.3M, but it is small versus the net loss, and capex is reported as $0. Dividends paid were about -$4.5M, which is large relative to FCF, suggesting cash planning risk.
Leverage & Balance Sheet
Net debt of $965.0M against equity of $219.1M indicates very high leverage. This can constrain resilience and increases sensitivity to operating performance.
Shareholder Returns
Total shareholder value creation appears weak: the stock fell -52.2% over 1 year and -37.9% over 6 months. Dividends are present but modest, and buybacks are not disclosed.
Analyst Sentiment & Valuation
Key valuation inputs (P/E, FCF yield, ROE, analyst targets) are missing, limiting a quantitative valuation assessment. With substantial losses and high leverage, downside risk likely dominates.
Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.